Drug therapy of hyperlipidemias
Wolfram, G.
Wiener Medizinische Wochenschrift 131(13-14): 333-338
1981
ISSN/ISBN: 0043-5341 PMID: 7281700 Document Number: 174236
Document emailed within 1 workday
Related Documents
Schlierf, G.; Kahlke, W. 1972: Therapy of essential hyperlipidemias Minerva Medica 63(14): 853-855Oehme, P.; Brüschke, G.; Kluchert, K.; Krüger, U. 1970: Current problems of drug therapy. 9. Stationary and ambulatory drug therapy. 2 Das Deutsche Gesundheitswesen 25(21): 957-960
Cox, R.A. 2003: The hyperlipidemias Boletin de la Asociacion Medica de Puerto Rico 95(5): 36-44
Assmann, G.; Schriewer, H. 1980: The diagnosis of hyperlipidemias Therapeutische Umschau. Revue Therapeutique 37(11): 965-972
Hidalgo Vicario, M.I. 1991: Diagnosis of hyperlipidemias Anales Espanoles de Pediatria 35 Suppl 45(4): 12-16
Mori, S.; Ito, H. 2007: Classification of hyperlipidemias in Japan Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 237-240
Assmann, G. 1979: Current diagnosis of hyperlipidemias Der Internist 20(11): 559-564
Lugo-Somolinos, A.íd.; Sánchez, J.E. 2003: Xanthomas: a marker for hyperlipidemias Boletin de la Asociacion Medica de Puerto Rico 95(4): 12-16
Feder, D.; Langer, A.L.; Alexandrino, E.; Medeiros, S.; Lotto, M.; Valente, O. 1986: Probucol in the treatment of hyperlipidemias Arquivos Brasileiros de Cardiologia 46(2): 77-80
Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645
Iimori, M. 2005: Psychotherapy and drug therapy--drug therapy within the framework of psychotherapy and psychotherapy conducted during drug therapy Seishin Shinkeigaku Zasshi 107(5): 500-505
Berg, K. 1982: The genetics of the hyperlipidemias and coronary artery disease Progress in Clinical and Biological Research 103 Pt B: 111-125
Schoonmaker, F.W.; King, S.B.; Vijay, N.K. 1973: Hyperlipidemias in predicting coronary artherosclerosis by arteriography Rocky Mountain Medical Journal 70(8): 32-36
Buxtorf, J.C.; Delplanque, B.; Baudet, M.F.; Beaumont, J.L. 1979: Lipid particles agglutinated in hyperlipidemias with opalescent sera La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 55(3-4): 193-197
Lipovetskiĭ, B.M. 1993: Genealogy and the clinical manifestations of familial hyperlipidemias types IIa and IIb Terapevticheskii Arkhiv 65(12): 34-38
Szczeklik, A. 1974: Differential diagnosis of hyperlipidemias and hypolipidemias in endocrinologic diseases Przeglad Lekarski 31(0): Suppl:79-82
Widhalm, K. 1985: Effect of diet on serum lipoproteins in children with various forms of hyperlipidemias Progress in Clinical and Biological Research 188: 145-159
Fujii, Y. 2001: Acute phase drug therapy and drug switching in the treatment of patients with schizophrenia Seishin Shinkeigaku Zasshi 103(12): 1030-1035
Vozeh, S. 1984: Drug level determination for optimization of drug therapy. Practical significance and new trends Schweizerische Rundschau für Medizin Praxis 73(49): 1505-1506
Lerch, C. 1994: Responsibility for patient education in drug therapy from the viewpoint of the drug industry Zeitschrift für Arztliche Fortbildung 88(12): 1055-1060